Health Condition 1: H401- Open-angle glaucoma
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients of either gender aged more than 18 years, baseline IOP more than18mmHg ,with a diagnosis in each eye of either: 2) Ocular hypertension 3) Chronic or primary open angle glaucoma 4) Chronic angle closure glaucoma with patent PI 5) Pseudoexfoliative glaucoma 6) Pigmentary glaucoma
Exclusion criteria
Exclusion criteria: 1) Known allergy, contraindication, hypersensitivity, or contraindication to the study medication or any of its components 2) active ocular disease other than glaucoma or OHT (except chronic mild blepharitis, cataract, age-related macular degeneration, or background diabetic retinopathy, which could be enrolled at the discretion of the investigator) 3) recent or anticipated changes in therapy for chronic conditions with agents that could affect IOP 4) corneal abnormalities that could preclude accurate IOP readings with applanation tonometry 5)use of corticosteroids within defined exclusion periods prior to baseline and through the study period 6) incisional surgery or laser procedure within defined exclusion periods prior to baseline
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| checking intraocular pressure on DAY 0, 2nd week, 6th week, 12th weekTimepoint: checking intraocular pressure on DAY 0, 2nd week, 6th week, 12th week | — |
Secondary
| Measure | Time frame |
|---|---|
| to check the efficacy and safety of the triple fixed dose combinationTimepoint: to check the efficacy and safety of the triple fixed dose combination | — |
Countries
India
Contacts
Public ContactDR SHIBI DEV BN
Nethradhama superspeciality eye hospital
Outcome results
None listed